PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
124.50M
Worse than ADAP's estimated revenue of 232.78M.
-24.90M
Better than ADAP's estimated ebitda of -199.99M.
0.56
Better than ADAP's estimated eps of 0.05.
16.74M
Better than ADAP's estimated net income of 12.62M.
-24.90M
Better than ADAP's estimated ebit of -202.93M.
4.61B
Worse than ADAP's estimated sg&a expense of 1.16B.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
1.14M
Worse than ADAP's revenue of 6.15M.
No Data
No DCF data available for this metric in the selected year.
-24.44M
Better than ADAP's ebitda of -155.68M.
-2136.36%
Better than ADAP's ebitda margin of -2531.78%.
-24.96M
Better than ADAP's ebit of -162.25M.
-2182.17%
Better than ADAP's ebit margin of -2638.56%.
524.00K
Better than ADAP's depreciation of 6.57M.
77.83M
Worse than ADAP's total cash of 369.58M.
6803.23%
Better than ADAP's cash as percentage of revenue of 6010.41%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
5.54M
Better than ADAP's accounts payable of 8.11M.
483.83%
Worse than ADAP's payables as percentage of revenue of 131.94%.
-133.00K
Worse than ADAP's capital expenditure of -8.78M.
-11.63%
Worse than ADAP's capex as percentage of revenue of -142.80%.
4.99%
Better than ADAP's weighted average cost of capital (wacc) of 6.28%.
5.02%
Better than ADAP's cost of equity of 17.51%.
4.08%
Better than ADAP's cost of debt of 4.51%.
-0.23
Better than ADAP's beta of 2.85.
30.07M
Better than ADAP's diluted shares outstanding of 42.05M.
1.57M
Better than ADAP's total debt of 74.21M.
49.31M
Better than ADAP's total equity of 11.69M.
50.89M
Worse than ADAP's total capital of 85.89M.
3.09%
Better than ADAP's debt weighting of 86.40%.
96.91%
Better than ADAP's equity weighting of 13.60%.
-24.77M
Better than ADAP's ebiat of -163.06M.
-23.19M
Better than ADAP's unlevered free cash flow of -162.82M.
2.00%
Equal to ADAP's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than ADAP's net debt of -16.93M.
71.33M
Better than ADAP's equity value of -75.14B.
2.37
Better than ADAP's equity value per share of -1786.98.